These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16214600

  • 1. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC.
    Lancet; 2005 Oct 08; 366(9493):1296-300. PubMed ID: 16214600
    [Abstract] [Full Text] [Related]

  • 2. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.
    Invest Ophthalmol Vis Sci; 2007 Apr 08; 48(4):1492-7. PubMed ID: 17389476
    [Abstract] [Full Text] [Related]

  • 3. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.
    Lancet; 2007 Apr 08; 365(9467):1321-8. PubMed ID: 15823382
    [Abstract] [Full Text] [Related]

  • 4. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.
    N Engl J Med; 2004 Nov 04; 351(19):1962-71. PubMed ID: 15525721
    [Abstract] [Full Text] [Related]

  • 5. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC.
    J Infect Dis; 2011 Jul 15; 204(2):268-73. PubMed ID: 21673038
    [Abstract] [Full Text] [Related]

  • 6. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Bailey R, Foster A, Mabey D, West SK.
    Invest Ophthalmol Vis Sci; 2005 Jan 15; 46(1):83-7. PubMed ID: 15623758
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
    Cajas-Monson LC, Mkocha H, Muñoz B, Quinn TC, Gaydos CA, West SK.
    PLoS Negl Trop Dis; 2011 Mar 15; 5(3):e978. PubMed ID: 21423645
    [Abstract] [Full Text] [Related]

  • 8. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD, Tadesse Z, Gebresillasie S, Shiferaw A, Zerihun M, Emerson PM, Callahan K, Cotter SY, Stoller NE, Porco TC, Oldenburg CE, Lietman TM.
    PLoS Med; 2018 Aug 15; 15(8):e1002633. PubMed ID: 30106956
    [Abstract] [Full Text] [Related]

  • 9. Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?
    West SK, Stare D, Mkocha H, Munoz B, Gaydos C, Quinn TC.
    Invest Ophthalmol Vis Sci; 2011 Jul 29; 52(8):6040-2. PubMed ID: 21680866
    [Abstract] [Full Text] [Related]

  • 10. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J, Munoz B, Mkocha H, Gaydos CA, Bailey R, Lietman TA, Quinn T, West SK.
    JAMA Ophthalmol; 2013 Apr 29; 131(4):431-6. PubMed ID: 23392481
    [Abstract] [Full Text] [Related]

  • 11. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM, Holland MJ, Schémann JF, Sillah A, Sarr B, Christerson L, Pickering H, Molina-Gonzalez S, Sarr I, Andreasen AA, Jeffries D, Grundy C, Mabey DCW, Herrmann B, Bailey RL.
    Parasit Vectors; 2019 Oct 22; 12(1):497. PubMed ID: 31640755
    [Abstract] [Full Text] [Related]

  • 12. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
    Broman AT, Shum K, Munoz B, Duncan DD, West SK.
    Invest Ophthalmol Vis Sci; 2006 Jan 22; 47(1):99-104. PubMed ID: 16384950
    [Abstract] [Full Text] [Related]

  • 13. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM, Derrick T, Macleod D, Massae P, Malisa A, Mbuya K, Mtuy T, Makupa W, Roberts CH, Bailey RL, Mabey DCW, Holland MJ, Burton MJ.
    PLoS Negl Trop Dis; 2019 Jul 22; 13(7):e0007559. PubMed ID: 31306419
    [Abstract] [Full Text] [Related]

  • 14. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK, Moncada J, Munoz B, Mkocha H, Storey P, Hardick J, Gaydos CA, Quinn TC, Schachter J.
    J Infect Dis; 2014 Jul 01; 210(1):65-71. PubMed ID: 24446528
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T, Harding-Esch EM, Hailu G, Andreason A, Mabey DC, Todd J, Cumberland P.
    Trop Med Int Health; 2008 Apr 01; 13(4):556-65. PubMed ID: 18282237
    [Abstract] [Full Text] [Related]

  • 16. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
    Marks M, Bottomley C, Tome H, Pitakaka R, Butcher R, Sokana O, Kako H, Solomon AW, Mabey DC.
    Sex Transm Infect; 2016 Jun 01; 92(4):261-5. PubMed ID: 26888658
    [Abstract] [Full Text] [Related]

  • 17. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ, Holland MJ, Makalo P, Aryee EA, Sillah A, Cohuet S, Natividad A, Alexander ND, Mabey DC, Bailey RL.
    PLoS Negl Trop Dis; 2010 Oct 05; 4(10):. PubMed ID: 20957147
    [Abstract] [Full Text] [Related]

  • 18. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.
    West S, Muñoz B, Bobo L, Quinn TC, Mkocha H, Lynch M, Mmbaga BB, Viscidi R.
    Invest Ophthalmol Vis Sci; 1993 Oct 05; 34(11):3194-8. PubMed ID: 8407229
    [Abstract] [Full Text] [Related]

  • 19. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
    Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Porco TC, Keenan JD, Lietman TM, Oldenburg CE.
    Ophthalmic Epidemiol; 2019 Aug 05; 26(4):231-237. PubMed ID: 30957594
    [Abstract] [Full Text] [Related]

  • 20. Targeting antibiotics to households for trachoma control.
    Blake IM, Burton MJ, Solomon AW, West SK, Basáñez MG, Gambhir M, Bailey RL, Mabey DC, Grassly NC.
    PLoS Negl Trop Dis; 2010 Nov 02; 4(11):e862. PubMed ID: 21072225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.